Fennec Pharmaceuticals (FENC) Invested Capital (2021 - 2025)

Fennec Pharmaceuticals' Invested Capital history runs 5 years deep, the most recent figure standing at $18.2 million for Q3 2025.

• Quarterly Invested Capital fell 39.31% year-over-year to $18.2 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $54.6 million (down 49.52% YoY) and the FY2024 annual result came in at $18.2 million, down 39.31% from the prior year.
• Invested Capital was $18.2 million for Q3 2025 at Fennec Pharmaceuticals, roughly flat from $18.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $30.0 million in Q4 2023 and bottomed at $500000.0 in Q1 2022.
• A 5-year average of $18.2 million and a median of $18.2 million in 2024 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital sank 80.0% — and 2023, when it jumped 4900.0%.
• Fennec Pharmaceuticals' Invested Capital stood at $5.0 million in 2021, then surged by 400.0% to $25.0 million in 2022, then advanced by 20.0% to $30.0 million in 2023, then tumbled by 39.31% to $18.2 million in 2024, then changed by 0.0% to $18.2 million in 2025.
• Business Quant data shows FENC's Invested Capital at $18.2 million in Q3 2025, $18.2 million in Q2 2025, and $18.2 million in Q1 2025.